/Quest%20Diagnostics%2C%20Inc_%20logo%20on%20building-by%20Tada%20Images%20via%20Shutterstock.jpg)
Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the United States. Valued at a market cap of $21.8 billion, the company develops and delivers diagnostic information services, including routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
DGX is expected to release its Q1 2026 earnings on Tuesday, Apr. 21, before the market opens. Ahead of the event, analysts expect the company’s EPS to be $2.35 on a diluted basis, up 6.3% from $2.21 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.